Pablo Antúnez-Muiños: PLATEBRISK Study – Review of Simplified Antithrombotic Regimen after LAAO
EuroIntervention shared on X:
”The PLATEBRISK study suggests that a simplified antithrombotic regimen after LAAO is as effective as conventional treatment for high bleeding risk patients, with a lower rate of major bleeding in those with a history of bleeding. Pablo Antúnez-Muiños”
Article: A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study
Authors: Pablo Antúnez-Muiños, Sergio López-Tejero, Pedro Cepas-Guillén, Matias Mon-Noboa, Juan M. Ruiz-Nodar, Luis Andrés-Lalaguna, Fernando Rivero, Juan Gabriel Córdoba-Soriano, Ignacio J. Amat-Santos, Berenice Caneiro-Queija, David Martí Sánchez, Javier Jimeno Sánchez, Fernando Torres Mezcua, Fabián Blanco-Fernández, Jorge Sanz Sánchez, Cristina Moreno-Ambroj, Rodrigo Estévez-Loureiro, Luis Nombela-Franco, Xavier Freixa-Rofastes, Ignacio Cruz-González
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show